ipilimumab,nivolumab
bms
['nivo', 'nivolumab', 'ipilimumab', 'novo ']
neoadjuvant nivolumab plus ipilimumab is safe and orchestrates de novo immune responses in patients with ... #cancernews #medlearn #oncology #cancer #canceruk #nhs #healtheducation #cancereducation 
Our Board @AndrewVOwen @David_ukan @MedicineGovSte @NusratMedicine @Sivaprakas4m_R 📽️ #Cancer #Oncology #Surgery #Education #NHS #CancerEquity #CancerEducation